Zoic Capital
Overview
Zoic Capital is a venture capital firm founded in 2014 that invests in ventures from Seed to Series A. The firm focuses on frontier technologies and hard science, particularly in the health technology sector, that are backed by robust intellectual property. Zoic Capital aims to address the systematic underfunding of early-stage health technology startups and provides strategic and operational value beyond capital.
Portfolio Companies
5
Website
zoiccapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HDT Bio Corp. | Feb 2021 | Seed | Lead |
| ChromaTan | - | Seed | Co-investor |
| Optina Diagnostics | Oct 2018 | Seed | Lead |
| Probius | Oct 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Neal Mody
Board Member, Co-Founder
John Milne
Chief Medical Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zoic Capital based?
Zoic Capital is headquartered in Seattle, Washington, United States.
When was Zoic Capital founded?
Founding year information for Zoic Capital is not publicly available.
How many portfolio companies does Zoic Capital have?
Zoic Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Zoic Capital's portfolio?
Portfolio companies visible on Caplight include HDT Bio Corp., ChromaTan, Optina Diagnostics, Probius.
What was Zoic Capital's most recent investment shown here?
Zoic Capital's most recent investment in this portfolio sample was in Probius in 2022.
What sectors does Zoic Capital focus on?
Zoic Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Zoic Capital focus on?
Zoic Capital typically invests at the Early stage.